Stocks Health care GELS

NASDAQ · Health care

Gelteq Ltd (GELS)

It posted a net loss of $6.6M. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on November 17, 2025.

Watch GELS in 60 seconds

Follow GELS

Free, no password. An email when GELS files with the SEC.

Key facts about Gelteq Ltd

Net worth

Gelteq Ltd has a market value (market cap) of $4.5M at the latest share price. A company's "net worth" usually means this market value or the shareholders' equity on its balance sheet.

Latest report

The latest periodic report (annual report (foreign issuer), 20-F) was filed with the SEC on November 17, 2025 and covers the period to June 30, 2025. Open on SEC EDGAR

What Gelteq Ltd does

Gelteq Ltd is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker GELS.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Latest SEC filings

What Gelteq Ltd has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. July 6, 2026
   Foreign issuer update 6-K
2. June 30, 2026
   Foreign issuer update 6-K
3. June 2, 2026
   Foreign issuer update 6-K
4. May 26, 2026
   Foreign issuer update 6-K
5. March 24, 2026
   Foreign issuer update 6-K
6. December 9, 2025
   Foreign issuer update 6-K
7. November 17, 2025
   Annual report (foreign issuer) 20-F · period to June 30, 2025Diluted EPS -$0.72 versus -$0.44.
8. November 3, 2025
   Form NT 20-F filing NT 20-F
9. July 25, 2025
   IPO registration (foreign issuer) (amended) F-1/A
10. July 1, 2025
    IPO registration (foreign issuer) F-1

Recent insider filings (Forms 3, 4 and 144): 4, the latest on March 18, 2026. Insider transactions on SEC

Insider trades

What the people running Gelteq Ltd did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

All insider filings on SEC.gov · Where insiders are buying across the market

All filings on SEC EDGAR

Questions about GELS

What does Gelteq Ltd do?

Gelteq Ltd is a company in the Health care sector, listed on NASDAQ as GELS. Its shares trade on NASDAQ under the ticker GELS.

What is Gelteq Ltd's net worth?

Gelteq Ltd has a market value (market cap) of $4.5M at the latest share price. A company's "net worth" usually means this market value or the shareholders' equity on its balance sheet.

Is Gelteq Ltd profitable?

No. In fiscal 2025 it reported a net loss of $6.6M.

When did Gelteq Ltd last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on November 17, 2025. It covers the period to June 30, 2025. Its newest filing of any kind is the foreign issuer update from July 6, 2026.

Similar companies

Compare GELS with

Compare GELS with any company

Follow GELS

Get an email when Gelteq Ltd files with the SEC: results, executive changes, material agreements and annual reports.

Follow GELS

Free, no password. An email when GELS files with the SEC.

Where the numbers come from

Financial figures are the values Gelteq Ltd tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.